Breaking News

MS Pharma Inaugurates Biologics Manufacturing Facility in Saudi Arabia

Aims to establish a hub for advanced biopharmaceutical production in the MENA region.

Author Image

By: Charlie Sternberg

Associate Editor

MS Pharma has inaugurated a biologics manufacturing facility in Saudi Arabia. With formulation, fill & finish, and lyophilization capabilities, this $50 million investment positions MS Pharma as a trusted partner for global pharmaceutical companies seeking market access to Saudi Arabia and the MENA region through local manufacturing and contract manufacturing solutions for broader international markets. The factory is designed to meet the highest international regulatory standards, inc...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters